3,050 HCA Healthcare, Inc. $HCA Shares Acquired by Pzena Investment Management LLC

HCA Healthcare logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Pzena Investment Management increased its HCA stake by 3.2% in the third quarter, buying 3,050 shares to hold 99,648 shares valued at about $42.5 million.
  • HCA reported quarterly adjusted earnings of $7.22 per share and revenue of $19.85 billion, beating analyst estimates; revenue rose 3.6% year over year.
  • HCA declared a quarterly dividend of $0.78 per share, equivalent to an annualized $3.12 and a 0.6% yield.
  • Five stocks to consider instead of HCA Healthcare.

Pzena Investment Management LLC grew its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 3.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 99,648 shares of the company's stock after acquiring an additional 3,050 shares during the quarter. Pzena Investment Management LLC's holdings in HCA Healthcare were worth $42,524,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of HCA. MidFirst Bank purchased a new stake in HCA Healthcare during the second quarter valued at about $28,000. Clearstead Trust LLC acquired a new stake in HCA Healthcare during the second quarter worth about $29,000. Latitude Advisors LLC purchased a new position in shares of HCA Healthcare in the 3rd quarter worth about $32,000. Cedar Mountain Advisors LLC acquired a new position in shares of HCA Healthcare in the 1st quarter valued at about $33,000. Finally, Delos Wealth Advisors LLC purchased a new position in HCA Healthcare in the second quarter valued at approximately $35,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Key Stories Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

HCA Healthcare Stock Up 10.3%

Shares of HCA Healthcare stock opened at $510.31 on Thursday. The business has a 50-day moving average price of $440.51 and a 200 day moving average price of $444.90. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52. The firm has a market cap of $106.60 billion, a P/E ratio of 16.91, a P/E/G ratio of 1.55 and a beta of 1.11.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Tuesday, October 27th. The company reported $7.22 EPS for the quarter, topping analysts' consensus estimates of $6.65 by $0.57. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The company had revenue of $19.85 billion for the quarter, compared to the consensus estimate of $19.33 billion. During the same quarter last year, the business posted $6.96 EPS. HCA Healthcare's quarterly revenue was up 3.6% compared to the same quarter last year. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 30.15 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 29th. Shareholders of record on Tuesday, December 15th will be paid a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, December 15th. This represents a $3.12 annualized dividend and a yield of 0.6%. HCA Healthcare's payout ratio is presently 10.34%.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Cantor Fitzgerald reiterated an "overweight" rating on shares of HCA Healthcare in a research note on Friday, October 2nd. BMO Capital Markets began coverage on shares of HCA Healthcare in a research note on Tuesday, September 22nd. They issued an "outperform" rating and a $495.00 target price on the stock. Jefferies Financial Group set a $450.00 price target on shares of HCA Healthcare in a research report on Tuesday, July 14th. TD Cowen increased their price target on HCA Healthcare from $460.00 to $486.00 and gave the company a "buy" rating in a report on Wednesday, October 28th. Finally, Bank of America raised their price objective on HCA Healthcare from $450.00 to $500.00 and gave the company a "neutral" rating in a research report on Wednesday, October 28th. Sixteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $480.13.

Read Our Latest Research Report on HCA Healthcare

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women's and children's services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.

Recommended Stories

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in HCA Healthcare Right Now?

Before you consider HCA Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.

While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines